Brind.

Immuron anticipates receiving FDA approval for its IND submission.

5 reports, 3 independent Updated Oct 13
Gone quiet
Reports
5
Developments
4
Repetition
20%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 3 independent outlets

Immuron anticipates receiving FDA approval for its IND submission.

Who's involved

What this event is mainly about
ImmuronFDA

How it developed

Newest first. Tap a step to see who reported it.
  1. Immuron released trial data in Scientific Reports, supported by DoD funding.1 source
  2. Immuron seeks FDA IND approval and receives DoD funding for research with Walter Reed.1 source
  3. Immuron secured FDA IND approval and established three Australian clinical sites.1 source
  4. Immuron anticipates FDA approval for its IND submission.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • manilatimes.net
  • finanznachrichten.de
  • manilatimes.net
  • GlobeNewswireImmuron partners with InvestorHub MELBOURNE, Australia, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN) advises it has entered into a partnership with InvestorHub, a direct
  • GlobeNewswireImmuron - FY25 global sales exceed projection, up 49% on prior year Sales Highlights (unaudited): MELBOURNE, Australia, July 17, 2025 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an